Literature DB >> 28738289

Germinal center enhancement by extended antigen availability.

Kimberly M Cirelli1, Shane Crotty2.   

Abstract

Vaccine elicitation of protective antibody responses has proved difficult for a number of important human pathogens, including HIV-1. The amount of somatic hypermutation associated with the development of broadly neutralizing antibodies against HIV has not been achieved using conventional immunization strategies. An underexplored aspect of vaccine design is modulation of antigen kinetics. Immunization strategies with extended antigen availability have recently been shown to enhance humoral responses. In this review, we explore the mechanisms through which sustained antigen availability can enhance germinal center responses and the potency of antibody responses. These potential mechanisms include shifting B cell recognition away from non-neutralizing immunodominant epitopes, altered kinetics of immune complex deposition, improved T follicular helper (Tfh) cell responses, enhanced affinity maturation, and enhanced development of B cell memory. Finally, we discuss immunization strategies that result in extended antigen availability.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28738289      PMCID: PMC5626612          DOI: 10.1016/j.coi.2017.06.008

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  36 in total

Review 1.  T follicular helper cell differentiation, function, and roles in disease.

Authors:  Shane Crotty
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Continuous antigen delivery from controlled release implants induces significant and anamnestic immune responses.

Authors:  J M Kemp; M Kajihara; S Nagahara; A Sano; M Brandon; S Lofthouse
Journal:  Vaccine       Date:  2002-01-15       Impact factor: 3.641

Review 3.  The role of antibodies in HIV vaccines.

Authors:  John R Mascola; David C Montefiori
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

4.  Regulated selection of germinal-center cells into the memory B cell compartment.

Authors:  Ryo Shinnakasu; Takeshi Inoue; Kohei Kometani; Saya Moriyama; Yu Adachi; Manabu Nakayama; Yoshimasa Takahashi; Hidehiro Fukuyama; Takaharu Okada; Tomohiro Kurosaki
Journal:  Nat Immunol       Date:  2016-05-09       Impact factor: 25.606

Review 5.  Progress in HIV-1 vaccine development.

Authors:  Barton F Haynes; M Anthony Moody; Munir Alam; Mattia Bonsignori; Laurent Verkoczy; Guido Ferrari; Feng Gao; Georgia D Tomaras; Hua-Xin Liao; Garnett Kelsoe
Journal:  J Allergy Clin Immunol       Date:  2014-06-26       Impact factor: 10.793

6.  A prolonged immune response to antigen delivered in poly (epsilon-caprolactone) microparticles.

Authors:  Lynn Slobbe; Natalie Medlicott; Euan Lockhart; Nigel Davies; Ian Tucker; Majid Razzak; Glenn Buchan
Journal:  Immunol Cell Biol       Date:  2003-06       Impact factor: 5.126

7.  Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

Authors:  Nicole A Doria-Rose; Chaim A Schramm; Jason Gorman; Penny L Moore; Jinal N Bhiman; Brandon J DeKosky; Michael J Ernandes; Ivelin S Georgiev; Helen J Kim; Marie Pancera; Ryan P Staupe; Han R Altae-Tran; Robert T Bailer; Ema T Crooks; Albert Cupo; Aliaksandr Druz; Nigel J Garrett; Kam H Hoi; Rui Kong; Mark K Louder; Nancy S Longo; Krisha McKee; Molati Nonyane; Sijy O'Dell; Ryan S Roark; Rebecca S Rudicell; Stephen D Schmidt; Daniel J Sheward; Cinque Soto; Constantinos Kurt Wibmer; Yongping Yang; Zhenhai Zhang; James C Mullikin; James M Binley; Rogier W Sanders; Ian A Wilson; John P Moore; Andrew B Ward; George Georgiou; Carolyn Williamson; Salim S Abdool Karim; Lynn Morris; Peter D Kwong; Lawrence Shapiro; John R Mascola
Journal:  Nature       Date:  2014-03-02       Impact factor: 49.962

8.  Antigen depot is not required for alum adjuvanticity.

Authors:  Sharon Hutchison; Robert A Benson; Vivienne B Gibson; Abigail H Pollock; Paul Garside; James M Brewer
Journal:  FASEB J       Date:  2011-11-21       Impact factor: 5.191

9.  Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.

Authors:  Matthias Pauthner; Colin Havenar-Daughton; Devin Sok; Joseph P Nkolola; Raiza Bastidas; Archana V Boopathy; Diane G Carnathan; Abishek Chandrashekar; Kimberly M Cirelli; Christopher A Cottrell; Alexey M Eroshkin; Javier Guenaga; Kirti Kaushik; Daniel W Kulp; Jinyan Liu; Laura E McCoy; Aaron L Oom; Gabriel Ozorowski; Kai W Post; Shailendra K Sharma; Jon M Steichen; Steven W de Taeye; Talar Tokatlian; Alba Torrents de la Peña; Salvatore T Butera; Celia C LaBranche; David C Montefiori; Guido Silvestri; Ian A Wilson; Darrell J Irvine; Rogier W Sanders; William R Schief; Andrew B Ward; Richard T Wyatt; Dan H Barouch; Shane Crotty; Dennis R Burton
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

10.  Distinct germinal center selection at local sites shapes memory B cell response to viral escape.

Authors:  Yu Adachi; Taishi Onodera; Yuki Yamada; Rina Daio; Makoto Tsuiji; Takeshi Inoue; Kazuo Kobayashi; Tomohiro Kurosaki; Manabu Ato; Yoshimasa Takahashi
Journal:  J Exp Med       Date:  2015-08-31       Impact factor: 14.307

View more
  42 in total

1.  Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations.

Authors:  Jacob T Martin; Christopher A Cottrell; Aleksandar Antanasijevic; Diane G Carnathan; Benjamin J Cossette; Chiamaka A Enemuo; Etse H Gebru; Yury Choe; Federico Viviano; Stephanie Fischinger; Talar Tokatlian; Kimberly M Cirelli; George Ueda; Jeffrey Copps; Torben Schiffner; Sergey Menis; Galit Alter; William R Schief; Shane Crotty; Neil P King; David Baker; Guido Silvestri; Andrew B Ward; Darrell J Irvine
Journal:  NPJ Vaccines       Date:  2020-08-05       Impact factor: 7.344

2.  Rate of Immune Complex Cycling in Follicular Dendritic Cells Determines the Extent of Protecting Antigen Integrity and Availability to Germinal Center B Cells.

Authors:  Theinmozhi Arulraj; Sebastian C Binder; Michael Meyer-Hermann
Journal:  J Immunol       Date:  2021-02-19       Impact factor: 5.422

3.  Viral Replicative Capacity, Antigen Availability via Hematogenous Spread, and High TFH:TFR Ratios Drive Induction of Potent Neutralizing Antibody Responses.

Authors:  Preethi Eldi; Geeta Chaudhri; Stephen L Nutt; Timothy P Newsome; Gunasegaran Karupiah
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

4.  Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice.

Authors:  Elinor Willis; Norbert Pardi; Kaela Parkhouse; Barbara L Mui; Ying K Tam; Drew Weissman; Scott E Hensley
Journal:  Sci Transl Med       Date:  2020-01-08       Impact factor: 17.956

5.  Mamu-B*17+ Rhesus Macaques Vaccinated with env, vif, and nef Manifest Early Control of SIVmac239 Replication.

Authors:  Mauricio A Martins; Damien C Tully; Núria Pedreño-Lopez; Benjamin von Bredow; Matthias G Pauthner; Young C Shin; Maoli Yuan; Noemia S Lima; David J Bean; Lucas Gonzalez-Nieto; Aline Domingues; Martin J Gutman; Helen S Maxwell; Diogo M Magnani; Michael J Ricciardi; Varian K Bailey; John D Altman; Dennis R Burton; Keisuke Ejima; David B Allison; David T Evans; Eva G Rakasz; Christopher L Parks; Myrna C Bonaldo; Saverio Capuano; Jeffrey D Lifson; Ronald C Desrosiers; Todd M Allen; David I Watkins
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

6.  Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles.

Authors:  Mariane Melo; Ely Porter; Yuan Zhang; Murillo Silva; Na Li; Brian Dobosh; Alessia Liguori; Pat Skog; Elise Landais; Sergey Menis; Devin Sok; David Nemazee; William R Schief; Ron Weiss; Darrell J Irvine
Journal:  Mol Ther       Date:  2019-08-19       Impact factor: 11.454

7.  Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance.

Authors:  Kimberly M Cirelli; Diane G Carnathan; Bartek Nogal; Jacob T Martin; Oscar L Rodriguez; Amit A Upadhyay; Chiamaka A Enemuo; Etse H Gebru; Yury Choe; Federico Viviano; Catherine Nakao; Matthias G Pauthner; Samantha Reiss; Christopher A Cottrell; Melissa L Smith; Raiza Bastidas; William Gibson; Amber N Wolabaugh; Mariane B Melo; Benjamin Cossette; Venkatesh Kumar; Nirav B Patel; Talar Tokatlian; Sergey Menis; Daniel W Kulp; Dennis R Burton; Ben Murrell; William R Schief; Steven E Bosinger; Andrew B Ward; Corey T Watson; Guido Silvestri; Darrell J Irvine; Shane Crotty
Journal:  Cell       Date:  2019-05-09       Impact factor: 41.582

8.  The magnitude of germinal center reactions is restricted by a fixed number of preexisting niches.

Authors:  Patricia Avancena; Tengfei Song; Yonghong Yao; Hannah Fehlner-Peach; Betty Diamond; Hua Gu; Klaus Rajewsky; Yong-Rui Zou
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-27       Impact factor: 11.205

9.  Ecto-NTPDase CD39 is a negative checkpoint that inhibits follicular helper cell generation.

Authors:  Wenqiang Cao; Fengqin Fang; Timothy Gould; Xuanying Li; Chulwoo Kim; Claire Gustafson; Simon Lambert; Cornelia M Weyand; Jörg J Goronzy
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

10.  Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge.

Authors:  Barbara K Felber; Zhongyan Lu; Xintao Hu; Antonio Valentin; Margherita Rosati; Christopher A L Remmel; Joshua A Weiner; Margaret C Carpenter; Katelyn Faircloth; Sherry Stanfield-Oakley; Wilton B Williams; Xiaoying Shen; Georgia D Tomaras; Celia C LaBranche; David Montefiori; Hung V Trinh; Mangala Rao; Munir S Alam; Nathan A Vandergrift; Kevin O Saunders; Yunfei Wang; Wes Rountree; Jishnu Das; Galit Alter; Steven G Reed; Pyone P Aye; Faith Schiro; Bapi Pahar; Jason P Dufour; Ronald S Veazey; Preston A Marx; David J Venzon; George M Shaw; Guido Ferrari; Margaret E Ackerman; Barton F Haynes; George N Pavlakis
Journal:  Cell Rep       Date:  2020-05-12       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.